Loading...

Aclaris Therapeutics, Inc.

0H8T.LLSE
Healthcare
Medical - Pharmaceuticals
£1.80
£0.03(1.69%)

Aclaris Therapeutics, Inc. (0H8T.L) Stock Competitors & Peer Comparison

See (0H8T.L) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
0H8T.L£1.81+1.69%185.9M-1.33-£1.36N/A
0R0H.L£491.54+0.36%185.6B25.62£19.19+0.33%
0QZU.L£389.24-2.06%99.8B41.08£9.48N/A
0M3Q.L£155.43-1.17%68.9B35.66£4.36+1.25%
0R2M.L£573.42-4.58%59.7B8.16£70.31+0.46%
0HD2.L£446.47-4.06%58.5B-59.61-£7.49N/A
0RD1.L£713.25+5.20%41.3B-549.21-£1.27N/A
0HAV.L£119.39+1.05%33.9B28.80£4.15+0.82%
0JDM.L£187.94+0.13%31.9B33.94£5.54N/A
0JAV.L£130.54-0.71%27.6B-34.56-£3.78N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

0H8T.L vs 0R0H.L Comparison August 2025

0H8T.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 0H8T.L stands at 185.9M. In comparison, 0R0H.L has a market cap of 185.6B. Regarding current trading prices, 0H8T.L is priced at £1.81, while 0R0H.L trades at £491.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

0H8T.L currently has a P/E ratio of -1.33, whereas 0R0H.L's P/E ratio is 25.62. In terms of profitability, 0H8T.L's ROE is -0.96%, compared to 0R0H.L's ROE of +0.13%. Regarding short-term risk, 0H8T.L is less volatile compared to 0R0H.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0H8T.L.Check 0R0H.L's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;